Literature DB >> 22574655

Comparison of cell expression formats for the characterization of GABA(A) channels using a microfluidic patch clamp system.

Qin Chen1, Peter D Yim, Nina Yuan, Juliette Johnson, James M Cook, Steve Smith, Cristian Ionescu-Zanetti, Zhi-Jian Wang, Leggy A Arnold, Charles W Emala.   

Abstract

Ensemble recording and microfluidic perfusion are recently introduced techniques aimed at removing the laborious nature and low recording success rates of manual patch clamp. Here, we present assay characteristics for these features integrated into one automated electrophysiology platform as applied to the study of GABA(A) channels. A variety of cell types and methods of GABA(A) channel expression were successfully studied (defined as I(GABA)>500 pA), including stably transfected human embryonic kidney (HEK) cells expressing α(1)β(3)γ(2) GABA(A) channels, frozen ready-to-assay (RTA) HEK cells expressing α(1)β(3)γ(2) or α(3)β(3)γ(2) GABA(A) channels, transiently transfected HEK293T cells expressing α(1)β(3)γ(2) GABA(A) channels, and immortalized cultures of human airway smooth muscle cells endogenously expressing GABA(A) channels. Current measurements were successfully studied in multiple cell types with multiple modes of channel expression in response to several classic GABA(A) channel agonists, antagonists, and allosteric modulators. We obtained success rates above 95% for transiently or stably transfected HEK cells and frozen RTA HEK cells expressing GABA(A) channels. Tissue-derived immortalized cultures of airway smooth muscle cells exhibited a slightly lower recording success rate of 75% using automated patch, which was much higher than the 5% success rate using manual patch clamp technique by the same research group. Responses to agonists, antagonists, and allosteric modulators compared well to previously reported manual patch results. The data demonstrate that both the biophysics and pharmacologic characterization of GABA(A) channels in a wide variety of cell formats can be performed using this automated patch clamp system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22574655      PMCID: PMC3419985          DOI: 10.1089/adt.2011.415

Source DB:  PubMed          Journal:  Assay Drug Dev Technol        ISSN: 1540-658X            Impact factor:   1.738


  30 in total

1.  A nonadherent cell-based HTS assay for N-type calcium channel using calcium 3 dye.

Authors:  Mary Lou Lubin; Tasha L Reitz; Matthew J Todd; Christopher M Flores; Ning Qin; Hong Xin
Journal:  Assay Drug Dev Technol       Date:  2006-12       Impact factor: 1.738

Review 2.  High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology.

Authors:  John Dunlop; Mark Bowlby; Ravikumar Peri; Dmytro Vasilyev; Robert Arias
Journal:  Nat Rev Drug Discov       Date:  2008-04       Impact factor: 84.694

Review 3.  Port-a-patch and patchliner: high fidelity electrophysiology for secondary screening and safety pharmacology.

Authors:  Cecilia Farre; Alison Haythornthwaite; Claudia Haarmann; Sonja Stoelzle; Mohamed Kreir; Michael George; Andrea Brüggemann; Niels Fertig
Journal:  Comb Chem High Throughput Screen       Date:  2009-01       Impact factor: 1.339

Review 4.  GABA(A) receptor diversity and pharmacology.

Authors:  H Möhler
Journal:  Cell Tissue Res       Date:  2006-08-26       Impact factor: 5.249

5.  Tonically active GABAA receptors in hippocampal pyramidal neurons exhibit constitutive GABA-independent gating.

Authors:  Melissa R McCartney; Tarek Z Deeb; Tricia N Henderson; Tim G Hales
Journal:  Mol Pharmacol       Date:  2006-11-07       Impact factor: 4.436

6.  Role of caveolin-1 in p42/p44 MAP kinase activation and proliferation of human airway smooth muscle.

Authors:  Reinoud Gosens; Gerald L Stelmack; Gordon Dueck; Karol D McNeill; Akira Yamasaki; William T Gerthoffer; Helmut Unruh; Abdelilah Soussi Gounni; Johan Zaagsma; Andrew J Halayko
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-04-14       Impact factor: 5.464

7.  Potent 4-arylalkyl-substituted 3-isothiazolol GABA(A) competitive/noncompetitive antagonists: synthesis and pharmacology.

Authors:  Dorte Krehan; Signe I Storustovu; Tommy Liljefors; Bjarke Ebert; Birgitte Nielsen; Povl Krogsgaard-Larsen; Bente Frølund
Journal:  J Med Chem       Date:  2006-02-23       Impact factor: 7.446

8.  Activation of endogenous GABAA channels on airway smooth muscle potentiates isoproterenol-mediated relaxation.

Authors:  George Gallos; Neil R Gleason; Yi Zhang; Sang-Woo Pak; J R Sonett; Jay Yang; Charles W Emala
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-09-12       Impact factor: 5.464

9.  GABAA receptors are expressed and facilitate relaxation in airway smooth muscle.

Authors:  Kentaro Mizuta; Dingbang Xu; Yaping Pan; George Comas; Joshua R Sonett; Yi Zhang; Reynold A Panettieri; Jay Yang; Charles W Emala
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-04-11       Impact factor: 5.464

10.  Endogenous gamma-aminobutyric acid modulates tonic guinea pig airway tone and propofol-induced airway smooth muscle relaxation.

Authors:  George Gallos; Neil R Gleason; Laszlo Virag; Yi Zhang; Kentaro Mizuta; Robert A Whittington; Charles W Emala
Journal:  Anesthesiology       Date:  2009-04       Impact factor: 7.892

View more
  2 in total

1.  Characterization of GABAA receptor ligands with automated patch-clamp using human neurons derived from pluripotent stem cells.

Authors:  Nina Y Yuan; Michael M Poe; Christopher Witzigmann; James M Cook; Douglas Stafford; Leggy A Arnold
Journal:  J Pharmacol Toxicol Methods       Date:  2016-08-18       Impact factor: 1.950

2.  Targeting Nitric Oxide Production in Microglia with Novel Imidazodiazepines for Nonsedative Pain Treatment.

Authors:  Amanda N Nieman; Guanguan Li; Nicolas M Zahn; Md Yeunus Mian; Brandon N Mikulsky; Dylan A Hoffman; Taylor M Wilcox; Alexander S Kehoe; Ian W Luecke; Michael M Poe; David Alvarez-Carbonell; James M Cook; Douglas C Stafford; Leggy A Arnold
Journal:  ACS Chem Neurosci       Date:  2020-06-18       Impact factor: 5.780

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.